Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil

Transplantation

Volumn 68, Issue 1, 1999, Pages 158-161

  Rothwell, Walter S ^a   Gloor, James M ^a   Morgenstern, Bruce Z ^a   Milliner, Dawn S ^a  

^a Mayo Eugenio Litta Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYCLOSPORIN A; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADOLESCENT; ALLOGRAFT; ANTIBACTERIAL ACTIVITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; GRAFT INFECTION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RECIPIENT; RETROSPECTIVE STUDY; VARICELLA ZOSTER VIRUS;

EID: 0033565532     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199907150-00030     Document Type: Article

References (15)

1. Feldhoff CM, Balfour HH, Simmons RL, Najarian JS, Mauer SM. Varicella in children with renal transplants. J Pediatr 1981; 98: 25.
2. Furth SL, Sullivan EK, Neu AM, Tejani A, Fivush BA. Varicella in the first year after renal transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1997; 1: 37.
3. Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C. Varicella and zoster in children after kidney transplantation: long-term results in vaccination. Pediatrics 1997; 99: 35.
4. Lynfield R, Herrin JT, Rubin RH. Varicella in pediatric renal transplant recipient. Pediatrics 1992; 90: 216.
5. Kashtan CE, Cook M, Chavers BM, Mauer SM, Nevins TE. Outcome of chickenpox in 66 pediatric renal transplant recipients. J Pediatr 1997; 131: 874.
6. Allison AC, Eugui EM. Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation. Transplant Proc 1994; 26: 3205.
7. Van der Woude FJ. Mycophenolate mofetil (RS 61443): nothing new under the sun or an important break-through in the field of transplantation? Nephrol Dial Transplant 1995; 10: 1112.
8. Anonymous. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. Transplantation 1996; 61: 722.
9. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225.
10. Gershon AA, LaRussa P. Varicella-zoster virus infections. In: Katz SL, Hotez PJ, eds. Krugman's infectious diseases of children. St Louis, MO: Mosby, 1998: 620.
11. Straus SE. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Int Med 1988; 108: 221.
12. Locksley RM, N.F., Sullivan KM, Meyers JD. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 1985; 152: 1172.
13. McGregor RS, Zitelli BJ, Urbach AH, Malatack JJ, Gartner JC. Varicella in pediatric orthotopic liver transplant recipients. Pediatrics 1989; 83: 256.
14. Provost PJ, Krah DL, Kuter BJ, et al. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 1991; 9: 111.
15. Stewart JA. Herpes simplex virus. In: Rose NR, de Marcario EC, Folds JD, Lane HC, Nakamura RM, eds. Manual of clinical laboratory immunology. Washington, DC: ASM Press, 1997: 625.